{"count": 188, "results": [{"_id": "34557007", "pmid": 34557007, "pmcid": "PMC8453852", "title": "Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus", "journal": "Diabetes Metab Syndr Obes", "authors": ["Jevtovic F"], "date": "2021-09-16T00:00:00Z", "doi": "10.2147/DMSO.S328694", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "", "meta_pages": "4043-4057", "score": 50273.426, "text_hl": "Combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Exercise in Management of @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@Metabolic Abnormalities@@@ Observed in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes Mellitus@@@", "citations": {"NLM": "Jevtovic F. Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus Diabetes Metab Syndr Obes. 2021;14():4043-4057. PMID: 34557007", "BibTeX": "@article{34557007, title={Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus}, author={Jevtovic F}, journal={Diabetes Metab Syndr Obes}, volume={14}, pages={4043-4057}}"}}, {"_id": "36438823", "pmid": 36438823, "pmcid": "PMC9691898", "title": "X-box binding protein 1: A new metabolic mediator and drug target of metformin?", "journal": "Front Pharmacol", "authors": ["Lou K", "Sun P", "Zhang C", "Jiang Q", "Pang S"], "date": "2022-11-11T00:00:00Z", "doi": "10.3389/fphar.2022.1013218", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "1013218", "score": 50267.426, "text_hl": "Our preliminary results demonstrate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ activates @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@ to reduce @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@TG@@@ synthesis by inhibiting the @GENE_XBP1 @GENE_7494 @@@XBP1@@@-mediated @GENE_DGAT2 @GENE_84649 @@@DGAT2@@@ pathway, at least in part, suggesting that @GENE_XBP1 @GENE_7494 @@@XBP1@@@ is a new metabolic mediator for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment of @DISEASE_Hypertriglyceridemia @DISEASE_MESH:D015228 @@@hypertriglyceridemia@@@ and associated @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic disease@@@.", "citations": {"NLM": "Lou K, Sun P, Zhang C, Jiang Q, Pang S. X-box binding protein 1: A new metabolic mediator and drug target of metformin? Front Pharmacol. 2022;13():1013218. PMID: 36438823", "BibTeX": "@article{36438823, title={X-box binding protein 1: A new metabolic mediator and drug target of metformin?}, author={Lou K and Sun P and Zhang C and Jiang Q and Pang S}, journal={Front Pharmacol}, volume={13}, pages={1013218}}"}}, {"_id": "34588398", "pmid": 34588398, "title": "Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction.", "journal": "Biosci Trends", "authors": ["Wang X", "Huang H", "Zhu Y", "Li S", "Zhang P", "Jiang J", "Xi C", "Wu L", "Gao X", "Fu Y", "Zhang D", "Chen Y", "Hu S", "Lai J"], "date": "2021-11-21T00:00:00Z", "doi": "10.5582/bst.2021.01317", "meta_date_publication": "2021 Nov 21", "meta_volume": "15", "meta_issue": "5", "meta_pages": "321-329", "score": 50267.367, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ acts on the gut-brain axis to ameliorate antipsychotic-induced @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic dysfunction@@@.", "citations": {"NLM": "Wang X, Huang H, Zhu Y, Li S, Zhang P, Jiang J, Xi C, Wu L, Gao X, Fu Y, Zhang D, Chen Y, Hu S, Lai J. Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction. Biosci Trends. 2021 Nov 21;15(5):321-329. PMID: 34588398", "BibTeX": "@article{34588398, title={Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction.}, author={Wang X and Huang H and Zhu Y and Li S and Zhang P and Jiang J and Xi C and Wu L and Gao X and Fu Y and Zhang D and Chen Y and Hu S and Lai J}, journal={Biosci Trends}, volume={15}, number={5}, pages={321-329}}"}}, {"_id": "35326230", "pmid": 35326230, "pmcid": "PMC8945168", "title": "Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice", "journal": "Antioxidants (Basel)", "authors": ["Choi JY", "Jang TW", "Song PH", "Choi SH", "Ku SK", "Song CH"], "date": "2022-03-18T00:00:00Z", "doi": "10.3390/antiox11030580", "meta_date_publication": "2022 Mar 18", "meta_volume": "11", "meta_issue": "3", "meta_pages": "", "score": 50265.758, "text_hl": "Thus, combination effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and LD were examined in a high-@CHEMICAL_Fats @CHEMICAL_MESH:D005223 @@@fat@@@ diet (HFD)-induced @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic disease@@@ @SPECIES_10090 @@@mouse@@@ model. ", "citations": {"NLM": "Choi JY, Jang TW, Song PH, Choi SH, Ku SK, Song CH. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice Antioxidants (Basel). 2022 Mar 18;11(3):. PMID: 35326230", "BibTeX": "@article{35326230, title={Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice}, author={Choi JY and Jang TW and Song PH and Choi SH and Ku SK and Song CH}, journal={Antioxidants (Basel)}, volume={11}, number={3}}"}}, {"_id": "36674447", "pmid": 36674447, "pmcid": "PMC9862386", "title": "The Synergistic Action of Metformin and Glycyrrhiza uralensis Fischer Extract Alleviates Metabolic Disorders in Mice with Diet-Induced Obesity", "journal": "Int J Mol Sci", "authors": ["Hong MK", "Han Y", "Park HJ", "Shin MR", "Roh SS", "Kwon EY"], "date": "2023-01-04T00:00:00Z", "doi": "10.3390/ijms24020936", "meta_date_publication": "2023 Jan 4", "meta_volume": "24", "meta_issue": "2", "meta_pages": "", "score": 50263.887, "text_hl": "The Synergistic Action of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and Glycyrrhiza uralensis Fischer Extract Alleviates @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@Metabolic Disorders@@@ in @SPECIES_10090 @@@Mice@@@ with Diet-Induced @DISEASE_Obesity @DISEASE_MESH:D009765 @@@Obesity@@@", "citations": {"NLM": "Hong MK, Han Y, Park HJ, Shin MR, Roh SS, Kwon EY. The Synergistic Action of Metformin and Glycyrrhiza uralensis Fischer Extract Alleviates Metabolic Disorders in Mice with Diet-Induced Obesity Int J Mol Sci. 2023 Jan 4;24(2):. PMID: 36674447", "BibTeX": "@article{36674447, title={The Synergistic Action of Metformin and Glycyrrhiza uralensis Fischer Extract Alleviates Metabolic Disorders in Mice with Diet-Induced Obesity}, author={Hong MK and Han Y and Park HJ and Shin MR and Roh SS and Kwon EY}, journal={Int J Mol Sci}, volume={24}, number={2}}"}}, {"_id": "36098489", "pmid": 36098489, "title": "Metformin encapsulated gold nanoparticles (MTF-GNPs): A promising antiglycation agent.", "journal": "Cell Biochem Funct", "authors": ["Alenazi F", "Saleem M", "Khaja ASS", "Zafar M", "Alharbi MS", "Hagbani TA", "Ashraf JM", "Qamar M", "Rafi Z", "Ahmad S"], "date": "2022-10-01T00:00:00Z", "doi": "10.1002/cbf.3738", "meta_date_publication": "2022 Oct", "meta_volume": "40", "meta_issue": "7", "meta_pages": "729-741", "score": 50261.38, "text_hl": "Further in vivo and clinical research are necessary to determine the therapeutic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MTF@@@-GNPs against @DISEASE_613784 @DISEASE_OMIM:613784 @@@AGE@@@-related and @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic disorders@@@.", "citations": {"NLM": "Alenazi F, Saleem M, Khaja ASS, Zafar M, Alharbi MS, Hagbani TA, Ashraf JM, Qamar M, Rafi Z, Ahmad S. Metformin encapsulated gold nanoparticles (MTF-GNPs): A promising antiglycation agent. Cell Biochem Funct. 2022 Oct;40(7):729-741. PMID: 36098489", "BibTeX": "@article{36098489, title={Metformin encapsulated gold nanoparticles (MTF-GNPs): A promising antiglycation agent.}, author={Alenazi F and Saleem M and Khaja ASS and Zafar M and Alharbi MS and Hagbani TA and Ashraf JM and Qamar M and Rafi Z and Ahmad S}, journal={Cell Biochem Funct}, volume={40}, number={7}, pages={729-741}}"}}, {"_id": "32535544", "pmid": 32535544, "pmcid": "PMC7296337", "title": "Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions", "journal": "Redox Biol", "authors": ["Apostolova N", "Iannantuoni F", "Gruevska A", "Muntane J", "Rocha M", "Victor VM"], "date": "2020-07-01T00:00:00Z", "doi": "10.1016/j.redox.2020.101517", "meta_date_publication": "2020 Jul", "meta_volume": "34", "meta_issue": "", "meta_pages": "101517", "score": 50261.258, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and gluconeogenesis", "citations": {"NLM": "Apostolova N, Iannantuoni F, Gruevska A, Muntane J, Rocha M, Victor VM. Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions Redox Biol. 2020 Jul;34():101517. PMID: 32535544", "BibTeX": "@article{32535544, title={Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions}, author={Apostolova N and Iannantuoni F and Gruevska A and Muntane J and Rocha M and Victor VM}, journal={Redox Biol}, volume={34}, pages={101517}}"}}, {"_id": "35454163", "pmid": 35454163, "pmcid": "PMC9029304", "title": "Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications", "journal": "Biomolecules", "authors": ["García-Sáenz M", "Lobaton-Ginsberg M", "Ferreira-Hermosillo A"], "date": "2022-04-14T00:00:00Z", "doi": "10.3390/biom12040574", "meta_date_publication": "2022 Apr 14", "meta_volume": "12", "meta_issue": "4", "meta_pages": "", "score": 50260.84, "text_hl": "This suggests that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might be useful for @SPECIES_9606 @@@patients@@@ with differentiated or poorly differentiated @DISEASE_Thyroid_Neoplasms @DISEASE_MESH:D013964 @@@thyroid cancer@@@ and @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic diseases@@@ such as @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ or @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "García-Sáenz M, Lobaton-Ginsberg M, Ferreira-Hermosillo A. Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications Biomolecules. 2022 Apr 14;12(4):. PMID: 35454163", "BibTeX": "@article{35454163, title={Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications}, author={García-Sáenz M and Lobaton-Ginsberg M and Ferreira-Hermosillo A}, journal={Biomolecules}, volume={12}, number={4}}"}}, {"_id": "36394921", "pmid": 36394921, "title": "Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.", "journal": "J Clin Psychopharmacol", "authors": ["Stogios N", "Hahn MK", "Lunsky Y", "Desarkar P", "Agarwal SM"], "date": "2023-01-01T00:00:00Z", "doi": "10.1097/JCP.0000000000001626", "meta_date_publication": "2023 Jan-Feb 01", "meta_volume": "43", "meta_issue": "1", "meta_pages": "60-63", "score": 50260.594, "text_hl": "Further research and randomized controlled trials are needed to examine the efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in this population.", "citations": {"NLM": "Stogios N, Hahn MK, Lunsky Y, Desarkar P, Agarwal SM. Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series. J Clin Psychopharmacol. 2023 Jan-Feb 01;43(1):60-63. PMID: 36394921", "BibTeX": "@article{36394921, title={Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.}, author={Stogios N and Hahn MK and Lunsky Y and Desarkar P and Agarwal SM}, journal={J Clin Psychopharmacol}, volume={43}, number={1}, pages={60-63}}"}}, {"_id": "33095288", "pmid": 33095288, "title": "Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats.", "journal": "Psychopharmacology (Berl)", "authors": ["Luo C", "Wang X", "Huang HX", "Mao XY", "Zhou HH", "Liu ZQ"], "date": "2021-01-01T00:00:00Z", "doi": "10.1007/s00213-020-05677-8", "meta_date_publication": "2021 Jan", "meta_volume": "238", "meta_issue": "1", "meta_pages": "239-248", "score": 50258.867, "text_hl": "Coadministration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ prevents @CHEMICAL_Olanzapine @CHEMICAL_MESH:D000077152 @@@olanzapine@@@-induced @<m>DISEASE_Metabolic_Diseases</m> @DISEASE_MESH:D008659 @@@metabolic dysfunction@@@ and regulates the gut-liver axis in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Luo C, Wang X, Huang HX, Mao XY, Zhou HH, Liu ZQ. Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats. Psychopharmacology (Berl). 2021 Jan;238(1):239-248. PMID: 33095288", "BibTeX": "@article{33095288, title={Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats.}, author={Luo C and Wang X and Huang HX and Mao XY and Zhou HH and Liu ZQ}, journal={Psychopharmacology (Berl)}, volume={238}, number={1}, pages={239-248}}"}}]}